fremanezumab has completed phase iii trials and is under review by the fda to prevent migraine and
. sign in to get notified via email when new comments are made.
.
.: "targeted cgrp small molecule antagonists for acute migraine therapy."
.
copyright 2018 npr. to see more, visit /www.npr.org/.
.